cinacalcet has been researched along with Bone Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cipriani, C; Minisola, S; Pepe, J | 1 |
| Chang, JF; Chiu, IJ; Hsieh, CY; Hsu, YH; Hung, KC; Hung, LY; Lu, KC; Syu, RS; Wang, TM; Wu, CC; Wu, MS; Wu, MY; Zheng, CM | 1 |
| Howell, BL; Powers, CA; St Peter, WL; Yusuf, AA | 1 |
| Bouquegneau, A; Delanaye, P; Eastell, R; Khwaja, A; Salam, S | 1 |
| Grey, A; Khan, A; Shoback, D | 1 |
| Aguilar, A; Andrés, E; Baas, J; Ballarin, J; Bover, J; Canal, C; Farré, N; Lloret, MJ; Marco, H; Olaya, M; Reyes, J; Trinidad, P | 1 |
| Andres, A; Gutierrez, E; Morales, E | 1 |
| Block, GA; Chertow, GM; Correa-Rotter, R; Drueke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TC; Moe, SM; Parfrey, PS; Wheeler, DC | 1 |
| Brown, JH; Leonard, N | 1 |
| Bilezikian, JP; Silverberg, SJ | 1 |
| Fadem, SZ; Moe, SM | 1 |
| Canaud, B; Torres, PU | 1 |
6 review(s) available for cinacalcet and Bone Diseases
| Article | Year |
|---|---|
Bone Disease after Kidney Transplantation.
Topics: Absorptiometry, Photon; Bone Density Conservation Agents; Bone Diseases; Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Fractures, Bone; Humans; Immunosuppression Therapy; Kidney Transplantation; Minerals; Osteoporosis; Parathyroid Hormone; Vitamin D; Vitamins | 2016 |
Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Topics: Bone Density Conservation Agents; Bone Diseases; Calcium; Cinacalcet; Consensus; Cost-Benefit Analysis; Diphosphonates; Hormone Replacement Therapy; Humans; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone; Patient Selection; Treatment Outcome | 2009 |
Calcimimetics in the chronic kidney disease-mineral and bone disorder.
Topics: Bone Diseases; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes | 2009 |
Treatment with calcimimetics in kidney transplantation.
Topics: Bone Diseases; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Transplantation; Minerals; Naphthalenes; Postoperative Complications; Survival Analysis; Vitamin D Deficiency | 2010 |
The diagnosis and management of asymptomatic primary hyperparathyroidism.
Topics: Bone Diseases; Cardiovascular Diseases; Cinacalcet; Diphosphonates; Estrogens; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Glands; Phosphates; Renal Insufficiency | 2006 |
Management of chronic kidney disease mineral-bone disorder.
Topics: Bone Density Conservation Agents; Bone Diseases; Calcifediol; Chronic Disease; Cinacalcet; Diet; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Failure, Chronic; Minerals; Naphthalenes; Parathyroid Hormone; Phosphates; Phosphorus; Vitamin D | 2007 |
1 trial(s) available for cinacalcet and Bone Diseases
| Article | Year |
|---|---|
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.
Topics: Australia; Bone Diseases; Calcimimetic Agents; Canada; Cardiovascular Diseases; Cinacalcet; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Naphthalenes; Prognosis; Renal Dialysis; Russia; Survival Rate; United States; Vitamin D | 2012 |
5 other study(ies) available for cinacalcet and Bone Diseases
| Article | Year |
|---|---|
Skeletal protection in patients with primary hyperparathyroidism.
Topics: Bone Diseases; Cinacalcet; Denosumab; Double-Blind Method; Humans; Hyperparathyroidism, Primary | 2020 |
Therapeutic Effect of Calcimimetics on Osteoclast-Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease.
Topics: Adult; Aged; Biomarkers; Bone Density; Bone Diseases; Bone Resorption; Calcimimetic Agents; Cinacalcet; Female; Humans; Male; Middle Aged; Osteoblasts; Osteoclasts; Osteogenesis; Outcome Assessment, Health Care; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase | 2020 |
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Cinacalcet; Drug Utilization; Female; Health Expenditures; Humans; Male; Medicare Part D; Middle Aged; Naphthalenes; Phosphate-Binding Proteins; Poverty; Renal Dialysis; Renal Insufficiency, Chronic; United States; Vitamin D; Young Adult | 2014 |
Persistent and symptomatic post-transplant hyperparathyroidism: a dramatic response to cinacalcet.
Topics: Aged; Bone Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism; Kidney Transplantation; Naphthalenes; Treatment Outcome | 2006 |
[How to slow down parathyroid hormone (PTH) secretion without the risk of inducing an adynamic bone disease].
Topics: Bone Diseases; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone | 2005 |